Personalized Natural Killer Cell Therapy
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
Arms / Cohorts
Experimental Arm 1:Myeloma Patients: Myeloablative Regimen 1
Accepting patients
Experimental Arm:Myeloma Patients: Non-myeloablative Regimen 2
Accepting patients
Experimental Arm:Myeloma Patients: Reduced Intensity Regimen 3
Accepting patients
MDS Patients: Myeloablative Regimen 1
Accepting patients
MDS Patients: Non-myeloablative Regimen 2
Accepting patients
MDS Patients: Reduced Intensity Regimen 3
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.